The current crop of COVID-19 vaccines will not effectively handle the new omicron variant, according to the CEO of one of the biggest shot producers, Moderna.
Stéphane Bancel predicts the existing vaccines will be much less effective against the omicron, warning it would take months to manufacture at scale a vaccine that can tackle the new strain, the Financial Times reported.
President Biden has described omicron as "a cause for concern, not a cause for panic," arguing the government's medical experts "Believe that the vaccines will continue to provide a degree of protection against severe disease."
Bancel points out that the vaccines focus on the coronavirus spike protein to boost immunity, and 32 of the 50 mutations in the omicron variant are on that protein.
While Biden's top health adviser, Dr. Anthony Fauci, has dismissed the power of natural immunity from a previous COVID infection, many scientists point to studies indicating its durability and effectiveness against variants is superior to the vaccines.
A former health adviser to the federal government, Dr. Paul Elias Alexander, has teamed with Dr. Harvey Risch of the Yale School of Medicine and others to compile a list of 135 studies indicating natural immunity to COVID-19 from a previous infection is superior to immunity afforded by vaccines.
"We should not force COVID vaccines on anyone when the evidence shows that naturally acquired immunity is equal to or more robust and superior to existing vaccines. Instead, we should respect the right of the bodily integrity of individuals to decide for themselves," Alexander writes for the Brownstone Institute.
https://www.wnd.com/2021/11/moderna-ceo-vaccines-wont-handle-new-coronavirus-variant/
No comments:
Post a Comment